Treatment of shock

Acta Clinica Belgica

Volumn 66, Issue 6, 2011, Pages 438-442

  De Backer, D ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; DOPAMINE; NORADRENALIN;

ARTERIAL PRESSURE; BLEEDING; CARDIOGENIC SHOCK; CONFERENCE PAPER; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPOTENSION; HYPOVOLEMIC SHOCK; LACTIC ACIDOSIS; LUNG EMBOLISM; SHOCK; TACHYCARDIA;

ADRENERGIC ALPHA-AGONISTS; BLOOD PRESSURE; CARDIOTONIC AGENTS; EPINEPHRINE; HUMANS; NOREPINEPHRINE; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 84255170539     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.2143/ACB.66.6.2062611     Document Type: Conference Paper

References (37)

1. Antonelli M, Levy M, Andrews PJ, et al. Hemodynamic monitoring in shock and implications for management: International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med 2007; 33: 575-590.
2. Varpula M, Tallgren M, Saukkonen K, et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31: 1066-1071. (Pubitemid 41125337)
3. Howell MD, Donnino M, Clardy P, et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007; 33: 1892-1899. (Pubitemid 47632250)
4. Nakajima Y, Baudry N, Duranteau J, et al. Effects of vasopressin, norepinephrine and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med 2006; 1752-1757. (Pubitemid 43810059)
5. Sennoun N, Montemont C, Gibot S, et al. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med 2007; 35: 1736-1740. (Pubitemid 46985878)
6. Sun Q, Tu Z, Lobo S, et al. Optimal Adrenergic Support in Septic Shock Due to Peritonitis. Anesthesiology. 2003; 98: 888-896. (Pubitemid 36373223)
7. Albanese J, Leone M, Garnier F, et al. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004; 126: 534-539. (Pubitemid 39093440)
8. LeDoux D, Astiz ME, Carpati CM, et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28: 2729-2732.
9. Bourgoin A, Leone M, Delmas A, et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 2005; 33: 780-786.
10. Levy B, Dusang B, Annane D, et al. Cardiovascular response to dopamine and early prediction of outcome. A prospective multicenter study. Crit Care Med 2005; 33: 2172-2177. (Pubitemid 41437467)
11. Asfar P, De Backer D, Meier-Hellmann A, et al. Clinical review: infl uence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock. Crit Care 2004; 8: 170-179. (Pubitemid 38735696)
12. Zhang H, De Jongh R, De Backer D, et al. Effects of alpha - and beta -adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock. Crit Care Med 2001; 29: 581-588. (Pubitemid 32225301)
13. De Backer D, Zhang H, Cherkhaoui S, et al. Effect of dobutamine on hepatosplanchnic hemodynamics in an experimental model of hyperdynamic endotoxic shock. Shock 2001; 15: 208-214. (Pubitemid 33599104)
14. De Backer D, Zhang H, Manikis P, et al. Regional effects of dobutamine in endotoxic shock. J Surg Res 1996; 65: 93-100. (Pubitemid 26367575)
15. De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34: 403-408. (Pubitemid 43145619)
16. van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24: 1580-1590. (Pubitemid 26313763)
17. De Backer D, Creteur J, Silva E, et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003; 31: 1659-1667. (Pubitemid 36714218)
18. Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997; 23: 282-287. (Pubitemid 27129993)
19. Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007; 370: 676-684. (Pubitemid 47299251)
20. Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34: 2226-2234.
21. Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 2011; 39: 450-455.
22. Loeb HS, Winslow EB, Rahimtoola SH, et al. Acute hemodynamic effects of dopamine in patients with shock. Circulation 1971; 44: 163-173.
23. Schreuder WO, Schneider AJ, Groeneveld ABJ, et al. Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Chest 1989; 95: 1282-1288.
24. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362: 779-789.
25. Meier-Hellmann A, Bredle DL, Specht M, et al. The effects of low-dose dopamine on splanchnic blood fl ow and oxygen uptake in patients with septic shock. Intensive Care Med 1997; 23: 31-37. (Pubitemid 27067893)
26. Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2010; 33: 375-380.
27. Martin C, Viviand X, Leone M, et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28: 2758-2765.
28. Boulain T, Runge I, Bercault N, et al. Dopamine therapy in septic shock: Detrimental effect on survival? J Crit Care 2009; 24: 575-582.
29. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock infl uence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006; 34: 589-597.
30. Vasu TS, Cavallazzi R, Hirani A, et al. Norepinephrine or dopamine for septic shock: a systematic review of randomized clinical trials. J Intensive Care Med 2011 Mar 24 [Epub ahead of print].
31. Havel C, Arrich J, Losert H, et al. Vasopressors for hypotensive shock. Cochrane. Database.Syst.Rev. 2011, 5: CD003709.
32. Tendal B, Nuesch E, Higgins JP, et al. Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study. BMJ 2011; 343: d4829.
33. De Backer D, Aldecoa C, Njimi H, Vincent J-L. Dopamine versus norepinephrine in the treatment of septic shock: a metaanalysis. Crit Care Med 2011 Oct 27 [Epub ahead of print].
34. Vincent JL, Roman A, De Backer D, et al. Oxygen Uptake/Supply dependency: Effects of short-term dobutamine infusion. Am Rev Respir Dis 1990; 142: 2-8.
35. De Backer D, Creteur J, Noordally O, et al. Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998; 157: 1219-1225.
36. Hayes MA, Timmins AC, Yau EHS, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330: 1717-1722. (Pubitemid 24171030)
37. Rivers E, Nguyen B, Havstadt S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.